Business
India is an important market for many multinational pharmaceutical, biotech or medical device companies. But it is also a challenging one.
Join Martina Rozumberkova for a conversation with Sushmit Bhattacharya about challenges facing multinational pharmaceutical companies operating in India, from important regulatory changes, including the Uniform Code for Pharmaceutical Marketing Practices (UCPMP) 2024, to emerging fraud schemes, including fraud in the Government e-Marketplace (GeM) and retailer incentive schemes.
More Episodes
Life Sciences Series: Regulatory risks in China
2025-01-14
23
2025-01-14
23
Decoding corporate investigations: fintech in Africa
2024-12-13
58
2024-12-13
58
Decoding corporate investigations: Women in Investigations
2024-10-14
110
2024-10-14
110
CFIUS and the 2024 US election
2024-10-03
101
2024-10-03
101
Is India a new hub for international disputes?
2024-04-25
102
2024-04-25
102
Dispute Diaries: Is there a route around Red Sea disputes?
2024-03-26
179
2024-03-26
179
The Good Idea: Critical minerals, critical impacts
2024-03-26
87
2024-03-26
87
Dispute Diaries - Litigation Funding: Unpacking PACCAR Inc
2023-11-09
115
2023-11-09
115
Dispute Diaries - Disclosures in Cross-Border Disputes
2023-08-10
150
2023-08-10
150
The Good Idea: Is ESG a good idea?
2023-06-01
14
2023-06-01
14
Get this podcast on your
phone, FREE
